Update on the cardiometabolic syndrome
1Division of Endocrinology, Diabetes, and Hypertension, State University of New York Downstate, Veterans Administration Medical Center, Brooklyn, New York, USA. jsowers@netmail.hscbklyn.edu
Clinical Cornerstone
|February 13, 2002
Summary
Cardiometabolic syndrome involves metabolic, hemodynamic, and renal issues, including obesity and insulin resistance. These factors increase cardiovascular disease risk, impacting both diabetic and non-diabetic individuals.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Disorders
Background:
- Cardiometabolic syndrome is a cluster of metabolic, hemodynamic, and renal abnormalities.
- Visceral obesity and insulin resistance are key features.
- Associated conditions include hypertension, dyslipidemia, hypercoagulability, and inflammation.
Purpose of the Study:
- To review the interrelationships of factors within cardiometabolic syndrome.
- To discuss the implications for cardiovascular disease risk.
- To explore the syndrome in relation to diabetes mellitus.
Main Methods:
- Literature review of current knowledge.
- Synthesis of information on metabolic, hemodynamic, and renal factors.
- Analysis of cardiovascular disease risk implications.
Main Results:
- Cardiometabolic syndrome encompasses visceral obesity, insulin resistance, hypertension, dyslipidemia, and inflammation.
- These components synergistically elevate the risk of cardiovascular morbidity and mortality.
- The syndrome's impact is significant in individuals with and without diabetes.
Conclusions:
- Understanding the interconnectedness of cardiometabolic factors is crucial.
- Early identification and management can mitigate cardiovascular risks.
- The syndrome presents a significant public health challenge, particularly concerning diabetes comorbidities.
More Related Videos
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...